BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Lecube A, Valladares S, López-Cano C, Gutiérrez L, Ciudin A, Fort JM, Reñé JM, Matias-Guiu X, de Torres I, Bueno M, Pallarés J, Baena JA. The Role of Morbid Obesity in the Promotion of Metabolic Disruptions and Non-Alcoholic Steatohepatitis by Helicobacter Pylori. PLoS One 2016;11:e0166741. [PMID: 27893763 DOI: 10.1371/journal.pone.0166741] [Cited by in Crossref: 9] [Cited by in F6Publishing: 10] [Article Influence: 1.3] [Reference Citation Analysis]
Number Citing Articles
1 Xu G, Ma S, Dong L, Mendez-sanchez N, Li H, Qi X. Relationship of Helicobacter pylori Infection with Nonalcoholic Fatty Liver Disease: A Meta-Analysis. Canadian Journal of Gastroenterology and Hepatology 2023;2023:1-13. [DOI: 10.1155/2023/5521239] [Reference Citation Analysis]
2 Ma Z, Chu X, Yan X, Wang W. Association between Helicobacter pylori infection and non-alcoholic fatty liver disease for Asian and non-Asian population: A systematic review and meta-analysis. Front Public Health 2022;10:1062942. [PMID: 36568787 DOI: 10.3389/fpubh.2022.1062942] [Reference Citation Analysis]
3 Wernly S, Wernly B, Semmler G, Völkerer A, Rezar R, Semmler L, Stickel F, Aigner E, Niederseer D, Datz C. Non-alcoholic fatty liver disease is not independently associated with Helicobacter pylori in a central European screening cohort. Minerva Med 2022;113:936-49. [PMID: 35384436 DOI: 10.23736/S0026-4806.22.07928-9] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 3.0] [Reference Citation Analysis]
4 Liu Y, Xu H, Zhao Z, Dong Y, Wang X, Niu J. No evidence for a causal link between Helicobacter pylori infection and nonalcoholic fatty liver disease: A bidirectional Mendelian randomization study. Front Microbiol 2022;13:1018322. [PMID: 36406444 DOI: 10.3389/fmicb.2022.1018322] [Reference Citation Analysis]
5 García-Gómez-Heras S, Fernández-Aceñero MJ, González G, Bolaños-Muñoz ML, Franco-Rodríguez R, Paredes-González J, Ruiz-Tovar J. Involvement of Helicobacter pylori in Preoperative Gastric Findings on a Bariatric Population. Int J Environ Res Public Health 2022;19:9088. [PMID: 35897458 DOI: 10.3390/ijerph19159088] [Reference Citation Analysis]
6 Lv Z, Shan X, Tu Q, Wang J, Chen J, Yang Y. Ginkgolide B treatment regulated intestinal flora to improve high-fat diet induced atherosclerosis in ApoE−/− mice. Biomedicine & Pharmacotherapy 2021;134:111100. [DOI: 10.1016/j.biopha.2020.111100] [Cited by in Crossref: 10] [Cited by in F6Publishing: 11] [Article Influence: 5.0] [Reference Citation Analysis]
7 Doulberis M, Papaefthymiou A, Srivastava DS, Exadaktylos AK, Katsinelos P, Kountouras J, Polyzos SA. Update on the association between non-alcoholic fatty liver disease and Helicobacter pylori infection. Int J Clin Pract 2021;75:e13737. [PMID: 32991019 DOI: 10.1111/ijcp.13737] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
8 Doulberis M, Srivastava S, Polyzos SA, Kountouras J, Papaefthymiou A, Klukowska-Rötzler J, Blank A, Exadaktylos AK, Srivastava DS. Active Helicobacter pylori Infection is Independently Associated with Nonalcoholic Steatohepatitis in Morbidly Obese Patients. J Clin Med 2020;9:E933. [PMID: 32235601 DOI: 10.3390/jcm9040933] [Cited by in Crossref: 23] [Cited by in F6Publishing: 24] [Article Influence: 7.7] [Reference Citation Analysis]
9 Polyzos SA, Kountouras J. Helicobacter pylori Infection: One More Contributor to Nonalcoholic Fatty Liver Disease Pathophysiology. J Clin Gastroenterol 2019;53:624-6. [PMID: 31033804 DOI: 10.1097/MCG.0000000000001218] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.8] [Reference Citation Analysis]
10 Mantovani A, Turino T, Altomari A, Lonardo A, Zoppini G, Valenti L, Tilg H, Byrne CD, Targher G. Association between Helicobacter pylori infection and risk of nonalcoholic fatty liver disease: An updated meta-analysis. Metabolism 2019;96:56-65. [DOI: 10.1016/j.metabol.2019.04.012] [Cited by in Crossref: 25] [Cited by in F6Publishing: 26] [Article Influence: 6.3] [Reference Citation Analysis]
11 Polyzos SA, Kountouras J. Helicobacter pylori infection and nonalcoholic fatty liver disease: Time for large clinical trials evaluating eradication therapy. Helicobacter 2019;24:e12588. [PMID: 30950170 DOI: 10.1111/hel.12588] [Cited by in Crossref: 14] [Cited by in F6Publishing: 12] [Article Influence: 3.5] [Reference Citation Analysis]
12 Castaño-Rodríguez N, Mitchell HM, Kaakoush NO. NAFLD, Helicobacter species and the intestinal microbiome. Best Pract Res Clin Gastroenterol 2017;31:657-68. [PMID: 29566909 DOI: 10.1016/j.bpg.2017.09.008] [Cited by in Crossref: 31] [Cited by in F6Publishing: 33] [Article Influence: 5.2] [Reference Citation Analysis]
13 Cherkas A, Golota S, Guéraud F, Abrahamovych O, Pichler C, Nersesyan A, Krupak V, Bugiichyk V, Yatskevych O, Pliatsko M, Eckl P, Knasmüller S. A Helicobacter pylori-associated insulin resistance in asymptomatic sedentary young men does not correlate with inflammatory markers and urine levels of 8-iso-PGF2-α or 1,4-dihydroxynonane mercapturic acid. Arch Physiol Biochem 2018;124:275-85. [PMID: 29105496 DOI: 10.1080/13813455.2017.1396346] [Cited by in Crossref: 8] [Cited by in F6Publishing: 5] [Article Influence: 1.3] [Reference Citation Analysis]